<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="94280">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02142855</url>
  </required_header>
  <id_info>
    <org_study_id>B13032014 SoMSGEM BBSRC3</org_study_id>
    <nct_id>NCT02142855</nct_id>
  </id_info>
  <brief_title>Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training</brief_title>
  <official_title>Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training: a Novel Temporospatial Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Biotechnology and Biological Sciences Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <authority>United Kingdom: University of Nottingham Medical School Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The first goal of this study is the follow young and older people over a period of 8 weeks
      to define the processes responsible for loss of muscle length and width in age-related
      muscle wasting (sarcopenia) and allow us to look at age-related differences in tendon.
      Secondly, we will assess two different exercise interventions for reversing human
      sarcopenia; one which involves shortening of  the muscle and the other which involves
      lengthening, whilst also studying why these exercises work the way they do. This project
      will have significant implications for our understanding of the control of skeletal muscle
      and tendon size in humans, particularly in relation to sarcopenia and the surrounding health
      issues.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Muscle protein synthesis</measure>
    <time_frame>0 - 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of muscle protein synthesis using D2O in young and older individuals and in response to 8 weeks concentric or eccentric exercise training</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tendon protein synthesis</measure>
    <time_frame>0 - 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Comparison of tendon protein synthesis in young and older individuals and in response to 8 weeks concentric or eccentric exercise training</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Muscle function</measure>
    <time_frame>0 - 8 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Muscle strength, force and power in young and older individuals and in response to 8 weeks concentric or eccentric exercise training</description>
  </other_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Old Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Older individuals (65-75 y) with no exercise intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old Concentric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Older individuals (65-75 y) studied before and after 8 weeks concentric exercise training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old Eccentric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Older individuals (65-75 y) studied before and after 8 weeks eccentric exercise training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Young individuals (18-30 y) with no exercise intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Concentric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Young individuals (18-30 y) studied before and after 8 weeks concentric exercise training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Young Eccentric</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Young individuals (18-30 y) studied before and after 8 weeks eccentric exercise training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Concentric Exercise Training</intervention_name>
    <description>8 weeks concentric exercise training, 3 x per week, 60% 1-RM; 4 x 12-15 repetitions, 2 min rest between sets</description>
    <arm_group_label>Old Concentric</arm_group_label>
    <arm_group_label>Young Concentric</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Eccentric Exercise Training</intervention_name>
    <description>8 weeks eccentric exercise training, 3 x per week, 60% 1-RM; 4 x 12-15 repetitions, 2 min rest between sets</description>
    <arm_group_label>Old Eccentric</arm_group_label>
    <arm_group_label>Young Eccentric</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male volunteers

          -  Body mass index 18-30 kg/m2

          -  Aged 18-35 and 65-75 years

        Exclusion Criteria:

          -  Participation in a formal exercise regime,

          -  A BMI &lt; 18 or &gt; 30 kg/m2,

          -  Active cardiovascular disease,

          -  Taking beta-adrenergic blocking agents, statins or non-steroidal anti-inflammatory
             drugs,

          -  Cerebrovascular disease,

          -  Respiratory disease,

          -  Metabolic disease,

          -  Active inflammatory bowel or renal disease,

          -  Malignancy,

          -  Recent steroid treatment (within 6 months) or hormone replacement therapy,

          -  Clotting dysfunction,

          -  Musculoskeletal or neurological disorders,

          -  Family history of early (&lt;55y) death from cardiovascular disease
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marco V Narici, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bethan E Phillips, PhD</last_name>
    <phone>01332 724731</phone>
    <email>beth.phillips@nottingham.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kenneth Smith, PhD</last_name>
    <phone>01332 724600</phone>
    <email>ken.smith@nottingham.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Nottingham</name>
      <address>
        <city>Derby</city>
        <state>Derbyshire</state>
        <zip>DE22 3DT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bethan E Phillips, PhD</last_name>
      <email>beth.phillips@nottingham.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Marco V Narici, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bethan E Phillips, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip J Atherton, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kenneth Smith, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul L Greenhaff, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nathaniel J Szewczyk, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 20, 2014</lastchanged_date>
  <firstreceived_date>May 16, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>volunteers</keyword>
  <keyword>young (18-30 y)</keyword>
  <keyword>older (65-75 y)</keyword>
  <keyword>age groups</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
